Preview

Problems of Endocrinology

Advanced search

Survival predictors in patients with ectopic acth syndrome

https://doi.org/10.14341/probl13144

Abstract

AIM: To determine significant factors affecting the survival of patients with ectopic ACTH syndrome (EAS).
MATERIALS AND METHODS: A multi-center, observational study with a retrospective analysis of patients with EAS. The end point of the study was the fatal outcome of patients from various causes. In order to identify predictors of survival or mortality, univariate and multifactorial Cox regression analyses were carried out. ROC-analysis was used to determine the prognostic threshold values of individual predictors. The survival analysis was carried out using the Kaplan-Mayer method. Statistical data processing was carried out by using IBM SPSS Statistics 23.
RESULTS: The age of patients at the time of diagnosis ranged from 12 to 76 years (Me 40 years [28;54]). The age of the studied population was 55 years [38; 64] for women and 42 years [32; 54] for men. The median period of observation was 50 months [13;91], with a maximum follow-up of 382 months. 92 patients (60,9%) had bronchopulmonary NET, 17 (11,3%) — thymic carcinoid, 8 — pancreatic NET, 5 –pheochromocytoma, 1– cecum NET, 1– appendix carcinoid tumor, 1 — medullary thyroid cancer and 26 (17,2%) patients had an occult NET. The primary tumor was removed in 101 patients (66,9%). Bilateral adrenalectomy was performed in 42 (27,8%) cases. Metastases were revealed in 23,2% (n=35) of patients. Relapse of the disease was observed in 24,4%, long-term remission was preserved in 64 patients (74,4%). Death occurred in 42 patients (28%). The average age of survivors was 47,0±15,2 versus 53,5±15,6 years for the deceased (p=0,022). The average survival time from diagnosis for the deceased was 32 months, Me 16,5 months [7;54]. Multivariate analysis revealed that the following factors have a direct impact on survival: age of diagnosis ≥51 years (OR 4,493; 95% CI 2,056–9,818, p<0,001), bronchopulmonary neuroendocrine tumor (NET) (OR 0,281; 95% CI 0,119–0,665, p=0,004), the presence of distant metastases (OR 2,489; 95% CI 1,141–5,427, p=0,022), late-night salivary cortisol (LNSC) ≥122,2 nmol/L (OR 2,493; 95% CI 1,014–6,128, p=0,047).
CONCLUSION: The prognosis of patients with EAS is influenced by the age of diagnosis, NET localization, distant metastases and level of LNSC. The most common cause of ectopic ACTH syndrome was bronchopulmonary NET which was associated with the best survival rate.

About the Authors

O. O. Golounina
I.M. Sechenov First Moscow State Medical University (Sechenov University)
Russian Federation

Olga O. Golounina

8-2 Trubetskaya street, 119991 Moscow

SPIN-код: 7793-2123


Competing Interests:

None



Zh. E. Belaya
Endocrinology Research Centre
Russian Federation

Zhanna E. Belaya - MD, PhD, Professor

Moscow

SPIN-код: 4746-7173


Competing Interests:

None



L. Ya. Rozhinskaya
Endocrinology Research Centre
Russian Federation

Liudmila Ya. Rozhinskaya - MD, PhD, Professor

Moscow

SPIN-код: 5691-7775


Competing Interests:

None



M. Yu. Pikunov
The National Medical Research Center of Surgery named after A. V. Vishnevsky
Russian Federation

Michail Yu. Pikunov - MD, PhD

Moscow

SPIN-код: 2337-5066


Competing Interests:

None



A. A. Markovich
The National Medical Research Center of Oncology named after N. N. Blokhin
Russian Federation

Alla A. Markovich - MD, PhD

Moscow


Competing Interests:

None



L. K. Dzeranova
Endocrinology Research Centre
Russian Federation

Larisa K. Dzeranova - MD, PhD

Moscow

SPIN-код: 2958-5555


Competing Interests:

None



E. I. Marova
Endocrinology Research Centre
Russian Federation

Evgeniya I. Marova - MD, PhD, Professor

Moscow


Competing Interests:

None



N. S. Kuznetsov
Endocrinology Research Centre
Russian Federation

Nikolay S. Kuznetsov - MD, PhD, Professor

Moscow

SPIN-код: 8412-1098


Competing Interests:

None



V. V. Fadeev
I.M. Sechenov First Moscow State Medical University (Sechenov University)
Russian Federation

Valentin V. Fadeev, MD - PhD, Professor

8-2 Trubetskaya street, 119991 Moscow

SPIN-код: 6825-8417


Competing Interests:

None



G. A. Melnichenko
Endocrinology Research Centre
Russian Federation

Galina A. Melnichenko - MD, PhD, Professor, Academician of the Russian Academy of Sciences

Moscow

SPIN-код: 8615-0038


Competing Interests:

None



I. I. Dedov
Endocrinology Research Centre
Russian Federation

Ivan I. Dedov, MD - PhD, Professor, Academician of the Russian Academy of Sciences

Moscow

SPIN-код: 5873-2280


Competing Interests:

None



References

1. Lacroix A, Feelders RA, Stratakis CA, Nieman LK. Cushing’s syndrome. Lancet. 2015;386(9996):913-927. doi: https://doi.org/10.1016/S0140-6736(14)61375-1

2. Feelders R, Sharma S, Nieman L. Cushing’s syndrome: epidemiology and developments in disease management. Clin Epidemiol. 2015;386(9996):281. doi: https://doi.org/10.2147/CLEP.S44336

3. Ilias I, Torpy DJ, Pacak K, et al. Cushing’s syndrome due to ectopic corticotropin secretion: twenty years’ experience at the National Institutes of Health. J Clin Endocrinol Metab. 2005;90(8):4955-4962. doi: https://doi.org/10.1210/jc.2004-2527

4. Golounina OO, Belaya ZE, Rozhinskaya LYa, et al. Clinical and laboratory characteristics and results of treatment of patients with ACTHproducing neuroendocrine tumors of various localization. Therapeutic Archive. 2021;93(10):1171-1178. (In Russ.). doi: https://doi.org/10.26442/00403660.2021.10.201102

5. Melnichenko GA, Dedov II, Belaya ZE, et al. Cushing’s disease: the clinical features, diagnostics, differential diagnostics, and methods of treatment. Problems of Endocrinology. 2015;61(2):55-77. (In Russ.). doi: https://doi.org/10.14341/probl201561255-77

6. Belaya ZE, Rozhinskaya LYa, Melnichenko GA, et al. The role of prolactin gradient and normalized ACTH/ prolactin ratio in the improvement of sensitivity and specificity of selective blood sampling from inferior petrosal sinuses for differential diagnostics of ACTH-dependent hypercorticism. Problems of Endocrinology. 2013;59(4):3-10. (In Russ.). doi: https://doi.org/10.14341/probl20135943-10

7. Dedov II, Belaya ZE, Sitkin II, et al. Significance of the method of selective blood collection from the inferior petrosal sinuses for differential diagnosis of ACTH-dependent hypercorticism. Problems of Endocrinology. 2009;55(6):35-40. (In Russ.). doi: https://doi.org/10.14341/probl200955635-40

8. Rindi G, Mete O, Uccella S, et al. Overview of the 2022 WHO Classification of Neuroendocrine Neoplasms. Endocr Pathol. 2022;33(1):115-154. doi: https://doi.org/10.1007/s12022-022-09708-2

9. Davi’ MV, Cosaro E, Piacentini S, et al. Prognostic factors in ectopic Cushing’s syndrome due to neuroendocrine tumors: a multicenter study. Eur J Endocrinol. 2017;176(4):453-461. doi: https://doi.org/10.1530/EJE-16-0809

10. Lase I, Strele I, Grönberg M, et al. Multiple hormone secretion may indicate worse prognosis in patients with ectopic Cushing’s syndrome. Hormones. 2020;19(3):351-360. doi: https://doi.org/10.1007/s42000-019-00163-z

11. Kamp K, Alwani RA, Korpershoek E, et al. Prevalence and clinical features of the ectopic ACTH syndrome in patients with gastroenteropancreatic and thoracic neuroendocrine tumors. Eur J Endocrinol. 2016;174(3):271-280. doi: https://doi.org/10.1530/EJE-15-0968

12. Isidori AM, Kaltsas GA, Pozza C, et al. The ectopic adrenocorticotropin syndrome: Clinical features, diagnosis, management, and longterm follow-up. J Clin Endocrinol Metab. 2006;91(2):371-377. doi: https://doi.org/10.1210/jc.2005-1542

13. Lococo F, Margaritora S, Cardillo G, et al. Bronchopulmonary Carcinoids causing Cushing Syndrome: Results from a Multicentric Study Suggesting a More Aggressive Behavior. Thorac Cardiovasc Surg. 2015;64(02):172-181. doi: https://doi.org/10.1055/s-0035-1555125

14. Sathyakumar S, Paul TV, Asha HS, et al. Ectopic Cushing syndrome: A 10-year experience from a tertiary care center in Southern India. Endocrine Practice. 2017;23(8):907-914. doi: https://doi.org/10.4158/EP161677.OR

15. Pikunov MY, Pechetov AA, Golounina OO, et al. Features of preparation and surgical aspects of treatment of patients with ACTH-producing neuroendocrine lung tumors. Endocrine Surgery. 2021;15(2):4-12. (In Russ.). doi: https://doi.org/10.14341/serg12721


Supplementary files

1. Figure 1. Localization of the source of ectopic ACTH production.
Subject
Type Исследовательские инструменты
View (162KB)    
Indexing metadata ▾
2. Figure 2. Overall survival of patients depending on the concentration of cortisol in the evening saliva.
Subject
Type Исследовательские инструменты
View (118KB)    
Indexing metadata ▾
3. Figure 3. Overall survival of patients with ACTH-ectopic syndrome depending on the location of the NET (Kaplan-Meier survival curves).
Subject
Type Исследовательские инструменты
View (163KB)    
Indexing metadata ▾
4. Figure 4. Overall survival of patients depending on the prevalence of the tumor process.
Subject
Type Исследовательские инструменты
View (119KB)    
Indexing metadata ▾

Review

For citations:


Golounina O.O., Belaya Zh.E., Rozhinskaya L.Ya., Pikunov M.Yu., Markovich A.A., Dzeranova L.K., Marova E.I., Kuznetsov N.S., Fadeev V.V., Melnichenko G.A., Dedov I.I. Survival predictors in patients with ectopic acth syndrome. Problems of Endocrinology. 2022;68(6):30-42. (In Russ.) https://doi.org/10.14341/probl13144

Views: 28757


ISSN 0375-9660 (Print)
ISSN 2308-1430 (Online)